Tongjitang Chinese Medicines Co. (ADR) (NYSE:TCM)

CAPS Rating: 3 out of 5

A vertically integrated and profitable specialty pharmaceutical company focusing on the development, manufacturing and marketing of modernized traditional Chinese medicine.

Recs

0
Player Avatar jeppsusc (< 20) Submitted: 8/24/2008 10:01:20 PM : Outperform Start Price: $3.76 TCM Score: +12.29

young stock undervalued

Featured Broker Partners


Advertisement